Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001114220-18-000039)

Filing Details

Accession Number:
0001114220-18-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-20 16:11:25
Reporting Period:
2018-04-18
Accepted Time:
2018-04-20 16:11:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1694459 A. Christine Carberry C/O Keryx Biopharmaceuticals, Inc.
One Marina Park Drive, 12Th Floor
Boston MA 02210		 Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-18 2,026 $4.83 115,176 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of a total of 2,026 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,084 shares of restricted stock on April 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  2. Includes 90,832 shares of restricted stock.